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Abstract Submission
Improving the palatability of colonoscopy preparations
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3
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Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United
States. The most reliable screening method of CRC is a colonoscopy which requires a 4-Liter
polymer with electrolytes preparation. Two in five patients are non-compliant to their
colonoscopy schedules, with many patients who abstain reporting refusal due to significant
discomfort associated with this preparation. Furthermore, there are distinct gender differences in
the tolerance of colonoscopy preparations in male and female populations. We hypothesize the
differences in clinic are a result of toxic effects of the drug associated with poor mixing by
individual patients. PEG, the drug, is approved by the FDA for use in medical devices and has
been recognized for many years as a biocompatible polymer but few studies have truly studied
the short-term and long-term effects of high concentrations of PEG. We studied the toxic effects
of the common preparations over a time frame of 2 hours, 12 hours, 24 hours, and 48 hours and
found that at higher concentrations of the drug, more cells were killed. We have developed an
oral capsule that dissolves in stomach acid to control the release of PEG – accurately controlling
the amount of drug that is ingested by patients and reducing adverse effects associated with the
taste colonoscopy preparations. We have looked at and evaluated the capsules for chemical
content and tested them with cells to confirm their safety.

